Search

everythinglearnresearchcommunity

for

Search:↓

PF-05314882 selectively activates androgen receptors without much effect on prostate and may help in prostate cancer treatment and hair loss prevention.

Women with AGA have more androstenedione and dihydrotestosterone, less copper and zinc; copper imbalance affects AGA; treatment improves hormones and minerals.

The conclusion is that androgenetic alopecia and senescent alopecia have unique gene changes, suggesting different causes and potential treatments for these hair loss types.

Low SHBG and high FAI, FT, and DHEAS levels are effective in identifying PCOS.

Vitamin E affects liver metabolism, enhancing stress resistance, reducing blood clotting, and altering hormone processing.

Bicalutamide, a drug with a good safety profile, is a promising new treatment for female pattern hair loss.

Certain interactions help prepare the androgen receptor for pairing and activation, which is important for its role in development and disease.

Blocking testosterone speeds up wound healing in males.

Blocking testosterone speeds up wound healing in males.

Gene differences found in hair follicles linked to male baldness.

Treating hirsutism in women often requires a mix of medications and cosmetic methods for best results.

Spironolactone reduces the number of androgen receptor sites in rat skin by blocking them with its metabolite.

Inflammation and immunity play a key role in androgenetic alopecia, with better treatment outcomes in certain immune-positive cases.

Metformin works better for adolescent girls with PCOS who have certain genetic variations.

Finasteride helps reduce prostate size and symptoms in BPH but is less effective than terazosin and works best for larger prostates.

Women with PCOS and androgenic alopecia have different triglyceride metabolism compared to those without hair loss.

People with early-onset androgenetic alopecia may have a higher risk of heart disease due to abnormal blood lipid levels.

Antiandrogens are the main treatment for hirsutism, with individualized care and safe, affordable options needed.

Different types of polycystic ovary syndrome show varying levels of insulin resistance, with the 'PHO' type being the most insulin resistant.

Increased PPARGC1α relates to hair thinning in common baldness.

Certain genetic variants increase the risk of resistance to hormone therapy in prostate cancer patients.

Androgens cause oil-producing skin cells with androgen receptors to mature and produce more oil.

Clascoterone cream could be used for other skin conditions affected by hormones.

Female mice with disrupted 5α-reductase 1 had significant metabolic issues, including stress response problems, insulin resistance, liver fat buildup, and obesity.

Women with PCOS have higher hair cortisol levels, which are linked to worse metabolic and inflammatory conditions.

High androgen levels in young women with PCOS are linked to higher blood pressure.

New treatments may restore cancer-blocking proteins, slow prostate cancer, identify drug targets, and potentially regrow hair.

Hormonal imbalances are important in the development of male pattern baldness.

Insulin resistance may contribute to hair loss in people with androgenic alopecia.

Stiripentol shows promise as a potential treatment for androgen-related diseases but needs more testing.